Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2140.3000 26.90 (1.27%)

NSE Jun 13, 2025 15:31 PM

56.80% Gain from 52W Low

Volume: 113.5K

Caplin Point Laboratories Ltd.

23 Apr 2025

2140.30

1.27%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Five Interesting Stocks Today - June 13, 2025

The Baseline | 13 Jun 2025, 04:44PM

Market closes lower, NCLT admits IREDA’s insolvency plea against Gensol Engineering

Trendlyne Marketwatch | 13 Jun 2025, 04:01PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets